MRNA Total Assets
Everything the company owns at each quarter end — the balance-sheet total, not a flow.
Total Assets
Latest: $10.96B (2026Q2)
| Period | Value |
|---|---|
| 2023Q1 | $24.12B |
| 2023Q2 | $21.88B |
| 2023Q3 | $19.45B |
| 2023Q4 | $18.43B |
| 2024Q1 | $16.73B |
| 2024Q2 | $15.68B |
| 2024Q3 | $15.80B |
| 2024Q4 | $14.14B |
| 2025Q1 | $12.70B |
| 2025Q2 | $12.01B |
| 2025Q3 | $12.13B |
| 2025Q4 | $12.34B |
| 2026Q1 | $11.49B |
| 2026Q2 | $10.96B |
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 9
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Shares Outstanding
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Total Assets
Total Assets
Total Assets
Latest Total Assets: $10.96B (2026Q2); -8.7% YoY; -21.6% CAGR (3.25y).
Across the 14 quarters from 2023Q1 to 2026Q2, Total Assets ranged from $10.96B in 2026Q2 to $24.12B in 2023Q1.